Aquacel Extra is Expertly Balanced
Hydrofiber™ Technology giving you the right benefits for your patients.
Expertly balanced for you and your patients needs
Choosing the right dressing for every patient and wound stage is a skill.
With so many options on the market, it can be a challenge to differentiate between them, as not all dressings will deliver the outcomes you need.
An ideal balanced dressing should meet you and your patients’ needs in every wound stage.
Does your current choice do all of this?
For you: |
---|
Maintains moist environment for healing1 |
Absorbs and retains excess exudate to prevent leakage and maceration2,3 |
Micro-contours to wound bed, leaving no gap4 |
Easy to apply and remove5 |
Longer wear time to optimise costs and workload6 |
Autolytic debridement for a cleaner wound bed7 |
Versatility for a range of indications and wound stages8 |
Passively manages bioburden minimising risk of infection or biofilm formation9 |
Progresses hard to heal wounds cost effectively6,10 |
Range of sizes and shapes for cavity wounds8,11 |
Strength to remove in one piece12 |
Minimal lateral wicking to prevent maceration and leakage2,3 |
Naturally sourced and biodegradable13 |
For your patients: |
---|
Reduces pain during dressing removal10 |
Provides comfort when wearing3,14-17 |
Convenient application and removal5 |
Fewer dressing changes reducing pain and number of visits18 |
Improves quality of life10,19 |
Soft and malleable for comfort20 |
Aquacel® Extra™ is expertly balanced with Hydrofiber™ Technology
100% Natural CMC* fibres:
- Sustainably sourced and biodegradable13
- Malleable, soft and comfortable20
- Easily cut to any size8
- 7 days wear time8
- Stitch-bonded for greater strength – dressing retains integrity upon removal21
Hydrofiber® with cohesive gelling action:
- Balances moisture for optimum wound-healing environment1
- Micro-contours to wound bed minimising the GAP for bacteria to proliferate14,20
- Locks in exudate and bacteria helping minimise cross-infection22
- Locks in MMPs that may delay or compromise wound healing23
- Aids autolytic debridement7
- High exudate management, minimising leakage even under compression2
- Vertical wicking to draw fluid away from wound bed, protecting peri-wound8
Aquacel® Extra™ Hydrofiber™ Technology expertly balances a range of wound-healing attributes
Hydrofiber® technology transforms into a cohesive gel to minimise pain at dressing changes and to provide a moist wound healing environment by balancing fluid level.1
Aquacel® Extra™ aids autolytic debridement9 by de-sloughing the wound bed, reducing infection and inflammation.7,9
Reducing lateral spread of fluid to help prevent3 and improve peri-wound skin maceration.10
Other gelling fibres or alginate dressings demonstrated much higher lateral wicking distance25, which may cause peri-wound skin maceration and leakage.3
Vertical wicking / absorption of Aquacel® Extra™ transfers fluid away from the wound bed, protecting periwound skin from maceration.2,26
Aquacel® Extra™ can be used in combination with ConvaMax™ and Aquacel® Foam to have a synergistic effect of Hydrofiber™ Technology layers.11 27-29
Aquacel® Extra™ absorbs up to 30 times its weight and retain its integrity 2,3,10,20,30 to minimise risk of excess exudate and leakage even under compression.2,3
Its high exudate absorption and retention has shown fewer dressing changes in clinical practice.6,18,19 Aquacel® Extra™ provides better absorbency and retention* than other fibres and alginate dressings.12
*under GSM per square meter calculation
Aquacel® Extra™ transforms into a gel that micro-contours to the wound bed, balancing moisture and leaving no gaps for bacteria to proliferate.3,14-17
CMC+BiCo fibres and PVA dressings do not conform to the wound bed, leaving gaps where bacteria can grow.5
Designed with high tensile strength to be removed in one piece easily5 and eliminating pain at dressing change.1
Aquacel® ExtraTM can be cut in any direction without compromising its integrity.8
Aquacel® ExtraTM has superior wet tensile strength* than other fibre and alginate dressings.12
In clinical practice, alginate dressings were difficult to remove due to dressings breaking up or being mistaken for devitalised tissue and being left in the wound.5
*Machine direction
Made from 100% natural cellulose, biodegradable and sustainably sourced fibres.13
Aquacel® Extra™ does not adhere to the wound bed minimising pain on removal, results in majority of patients were satisfied with its comfort10,19, unlike other dressing with synthetic fibres.31, 32
Aquacel® ExtraTM fibres immobilise bacteria, including pseudomonas and staphylococci. The gel helps minimise cross-infection9,22,33-35 and significantly sequesters proteinase, such as matrix metalloproteinase (MMP), within 24 hours.23
Aquacel® ExtraTM significantly removed more planktonic and mature biofilm bacteria than DACC dressings at most timepoints.34
Proven clinical outcomes in just 14 days
Results of a community setting survey of 1093 patients with hard-to-heal and acute wounds treated with Aquacel® dressings in 14 days.10
97%
of nurses love Aquacel® Extra™s ease of use10 Nurse satisfaction score: 8.64/102
73.8%
significantly increased granulation (p<0.024)10
88.1%
of wounds healed or improved10
Results of a community-based observation of 1,502 patients with acute and chronic wounds treated with Aquacel® Extra™ (and Aquacel® Foam) in 14 days.19
Wound characteristics at D0
- 48% shallow wounds - 52% cavity wounds
- Wounds older than 3 months represented 20% of the study number
- Moderate to significant exudate in 81% of cases
- 63% had a perilesional skin alteration
Results at D14
- Wound healing or improvement in 89% of cases
- 79% of wounds >90 days improved or healed at D14
Observed clinical benefits
- Benefits meeting the expectations of caregivers
Expertly balanced for a variety of wounds…
Aquacel® Extra™ can be used on a wide range of acute and hard-to-heal wounds such as:8
- Leg ulcers, including:
- Venous ulcers
- Arterial ulcers
- Diabetic ulcers including diabetic foot ulcers
- Pressure ulcers/injuries
- Surgical wounds
- Traumatic wounds
Aquacel® Ribbon35
- Diabetic foot ulcers
- Pressure ulcers/injuries
- Surgical wounds
- Traumatic wound
Expertly balanced to help you manage cost
How the cost of wound care breaks down:36
How Aquacel® Extra™ can aid cost savings
Aquacel® Extra™ has shown to aid cost savings by reducing dressings changes, healing wounds faster and freeing resources, like nurse time and bed days.
- A 12 week study of 131 leg ulcer patients Aquacel® Extra™ has shown better performance, wear time and cost-effectiveness vs alginate dressings6
- Significant longer wear time 3.63 days (p < 0.001)6
- Less mean time to healing – closure of 41.8 days vs. 56.9 days (p = 0.053)6
- Less average cost per healed subject (£59 vs. £92 per 1 cm2)6
- Exudate management in venous leg ulcers* using Aquacel® Extra™ produced sizeable cost savings vs. branded and non branded alginates in a budget impact model.37
- In a study of 1093 patients, 88.1% of wounds healed or improved in just 14 days.10
- In a study of 1502 patients with chronic (43%) and acute wounds (57%), 89% of wounds heal or improved in just 14 days, requiring 25% fewer dressing changes.38
- Using Aquacel® Extra™ as an alternative to gauze could reduce costs by 30% per patient over 8 weeks.39
- Could potentially save 100 bed days a year, and save £55,000 by reduce dressing change frequency, optimise wound healing and allow earlier patient discharge.18
Aquacel® Extra™ range
Code |
name |
Size in cm |
Pack size |
---|---|---|---|
413566 |
Aquacel® Extra™ |
5 x 5cm |
10 |
413567 |
Aquacel® Extra™ |
10 x 10cm |
10 |
413568 |
Aquacel® Extra™ |
15 x 15cm |
5 |
413569 |
Aquacel® Extra™ |
4 x 10cm |
10 |
413598 |
Aquacel® Extra™ |
4 x 20cm |
10 |
413599 |
Aquacel® Extra™ |
4 x 30cm |
10 |
420127 |
Aquacel® Extra™ |
1 x 45cm |
5 |
403770 |
Aquacel® Extra™ |
4 x 30cm |
5 |
References
1. Barnea Y, Amir A, Lesham D et al. (2004) ‘Clinical comparative study of Aquacel® and paraffin gauze dressing for split-skin donor site treatment’, Ann Plast Surg, 132-113.
2. Waring MJ, Parsons D. (2001) ‘Physico‐chemical characterisation of carboxymethylated spun cellulose fibres’, Biomaterials, 903‐912.
3. Walker M, Parsons D. (2010) ‘Hydrofiber® Technology: its role in exudate management’, 31-8.
4. Bowler P, Jones S, Towers V et al. (2010) ‘Dressing conformability and silver-containing wound dressings’, Wounds, 14–20.
5. Leek K. (2022) Exploring the differences between alginate & gelling fibre dressings for managing exudate and improving clinical outcomes. Wound Care Today Conference poster.
6. Harding KG, et al, (2001) ‘Cost and dressing evaluation of Hydrofiber® and alginate dressings in the management of community-based patients with chronic ulceration’. Wounds 229-36
7. Coutts P and Sibbald R. (2005) ‘The effect of a Silver containing Hydrofiber® dressing on superficial wound bed and bacterial balance of chronic wounds’, 348-356.
8. Aquacel Extra™ Instruction For Use 1738657V1.
9. White R. (2011) ‘Wound dressings and other topical treatment modalities in bioburden control’ Journal of Wound Care 431-439.
10. Carrere, C et al. (2021) ‘Community Setting Survey Evaluating Aquacel® Dressings’, Journal of Wound Care, VOL 30, (NO 9), 763-774.
11. Aquacel® Ribbon Instructions for Use 1738658V1.
12. AWC-2022-005 ver 3.0 Convatec (2022) Data on file.
13. By design https://www. tencel. com/true-carbon-zero
14. Hoekstra MJ et al. (2002) A histological comparison of acute inflammatory responses with a Hydrofiber or tulle gauze dressing. J Wound Care; 11(3): 113- 17.
15. Jones SA, Bowler PG, Walker M. (2005) ‘Antimicrobial activity of silver-containing dressings is influenced by dressing conformability with a wound surface’, Wounds, 263-270.
16. Parsons D, Bowler PG, Myles V, Jones SA.(2005) ‘Silver antimicrobial dressings in wound management: A comparison of characteristics’, Wounds, 222-232.
17. Bowler P, Jones S, Towers V et al. (2010) ‘Dressing conformability and silver-containing wound dressings’, Wounds, 14–20
18. Moore PJ, Foster L. (2000) ‘Cost benefits of two dressings in the management of surgical wounds’, Br J Nurs, 1128-1132.
19. Tomasi J, Claude Y, Lucas A. (2020) ‘The partner study: first results of two synergistics dressings in the management of acute and chronic wounds in community setting’. WUWHS.
20. Tickle J, (2012) ‘Effective management of exudate with Aquacel® Extra™, BrJCommNurs, 38-46.
21. WHRI3461 TA214 Convatec Inc. (2011) Data on file.
22. Bowler PG, Jones SA, Davies BJ, Coyle E. (1999) ‘Infection control properties of some wound dressings’, J Wound Care, 499-502.
23. Walker M, Bowler PG, Cochrane CA. (2007) ‘In vitro studies to show sequestration of matrix metalloproteinases by silver-containing wound care products’. Ostomy/Wound Management, 53(9): 18-25.
24. RPT-058919 Convatec (2023) Data on file.
25. RPT-065344 Convatec (2023) Data on file.
26. An open randomized comparative study to evaluate the performance of AQUACEL® Extra™ in venous leg ulcers. Convatec (2013) Data on file.
27. AQUACEL® Foam Instructions for Use 1714576V1.
28. WHRI5397 MS147 v2.0 Convatec (2017) Data on file.
29. WHRI3891 MA243 Convatec (2014) Data on file.
30. Williams C. (1999) An investigation of the benefits of Aquacel® Hydrofibre wound dressing.
Br J Nurs, 8(10):676–677, 680. https://doi.org/10.12968/ bjon.1999.8.10.6607.
31. Sopata M, Piasecki A, Sopata M. (2019) Scanning electron microscopic examination of absorption potency of various fibrous dressings. J Wound Care, 28(2): 82-88.
32. IWTN Intertek Test Report - Gravimetric and HNMR analysis on Biatain reinforced gelling fiber dressing.
33. Walker M, Hobot JA, Newman GR, Bowler PG. (2003) ‘Scanning electron microscopic examination of bacterial immobilisation in a carboxymethyl cellulose (AQUACEL®) and alginate dressings’, Biomaterials, 883-890.
34. Newman GR, Walker M, Hobot JA, Bowler PG. (2006) Visualisation of bacterial sequestration and bactericidal activity within hydrating Hydrofiber wound dressings. Biomaterials 27: 1129-1139.
35. Meredith K, Jones AA, Towers VL, Metcalf DG. (2023) Ability of Different Non-Antimicrobial Wound Dressings to Remove Bacteria from Surfaces Using in vitro Planktonic and Mature Biofilm Models, Chronic Wound Care Management and Research, 10: 1-9, DOI: 10.2147/CWCMR.S421986.
36. Guest JF, Fuller GW, Vowden P. (2020) Cohort study evaluating the burden of wounds to the UK’s National Health Service in 2017/2018: update from 2012/2013.
37. Yan S. (2012) ‘A budget impact analysis comparing a Hydrofiber® dressing to an alginate dressing in managing exuding venous leg ulcers in France’. Int Wound Journal 304- 313.
38. Tomasi J, Claude Y, Lucas A. (2020) ‘The partner study: first results of two synergistics dressings in the management of acute and chronic wounds in community setting’. WUWHS.
39. Guest JF and Ruiz, Francis J. (2005) ‘Modelling the cost implications of using carboxymethylcellulose dressing compared with gauze in the management of surgical wounds healing by secondary intention in the US and UK’. Current Medical Research and Opinion, VOL21 (NO 2).
*CMC = Carboxymethyl cellulose
**BiCo = Bicocomponent
***PVA = Polyvinyl alcohol